Toronto - Free Realtime Quote
CAD
BriaCell Therapeutics Corp. (BCT.TO)
5.25
+0.05
(+0.96%)
As of 11:12:33 AM EST. Market Open.
Loading chart for BCT.TO
- Previous Close
5.20 - Open
5.30 - Bid 5.14 x --
- Ask 5.25 x --
- Day's Range
5.25 - 5.32 - 52 Week Range
3.68 - 18.00 - Volume
523 - Avg. Volume
7,287 - Market Cap (intraday)
45.845M - Beta (5Y Monthly) 1.66
- PE Ratio (TTM)
-- - EPS (TTM)
-9.66 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
-- - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/10/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
BCT.TO
49.47%
S&P/TSX Composite index (^GSPTSE)
13.53%
1-Year Return
BCT.TO
66.98%
S&P/TSX Composite index (^GSPTSE)
20.95%
3-Year Return
BCT.TO
99.36%
S&P/TSX Composite index (^GSPTSE)
84.70%
5-Year Return
BCT.TO
99.71%
S&P/TSX Composite index (^GSPTSE)
67.53%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-99.64%
-
Return on Equity (ttm)
-214.79%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-34.9M
-
Diluted EPS (ttm)
-9.66
Balance Sheet and Cash Flow
-
Total Cash (mrq)
20.54M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-16.27M
